Speciality Medicines IPO GMP, Grey Market Premium Today

Check out Speciality Medicines IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Speciality Medicines IPO GMP is not started in grey market, lets wait for the IPO announcement. Stay tuned for the latest IPO GMP numbers of Speciality Medicines IPO.
Speciality Medicines IPO

Speciality Medicines IPO is to open on March 20, 2026. It is an SME IPO that will raise ₹29 crores. The Speciality Medicines IPO price band is fixed at ₹117 to ₹124 with a market lot of 2,000 Shares.

Speciality Medicines IPO GMP Live Rates day by day with Kostak rates.

DateIPO GMPGMP TrendGain
17 March₹--%

Speciality Medicines IPO Details

IPO Open DateMarch 20, 2026
IPO Close DateMarch 24, 2026
Face Value₹10 Per Equity Share
IPO Price Band₹117 to ₹124 Per Share
Issue SizeApprox ₹29.14 Crores
Fresh IssueApprox ₹29.14 Crores
Issue TypeBook build Issue
IPO ListingBSE SME
DRHP Draft ProspectusPDF
RHP Draft ProspectusPDF

Speciality Medicines IPO Dates

IPO Open Date:March 20, 2026
IPO Close Date:March 24, 2026
Basis of Allotment:March 25, 2026
Refunds:March 27, 2026
Credit to Demat Account:March 27, 2026
IPO Listing Date:March 30, 2026
IPO Bidding Cut-off Time:March 24, 2026 – 5 PM

Business Overview

To be updated soon


Speciality Medicines IPO GMP aka Grey Market Premium FAQs:


What is Speciality Medicines IPO GMP Today?

Speciality Medicines IPO GMP is ₹- as of today.

What is Speciality Medicines IPO Expected Returns?

Speciality Medicines IPO Expected Returns is -%.

Disclaimer:

  • IPO Grey Market Premium (Speciality Medicines IPO GMP) mention is valid for the specific date as mentioned in the header.
  • We are not buying and selling IPO forms on IPO Grey Market.
  • Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
  • Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *